indication-specific pricing

Market Access

HCP holding a vial with organ option holograms

Indication-specific pricing in England: Business as usual?

Leela Barham highlights data that shows that indication-specific pricing has been used in England for at least four years and over 60 times.

News

Tenpoint eyes presbyopia drug launch after FDA nod

Tenpoint is set to join the US market for drugs to treat presbyopia, taking on rival therapies from AbbVie, Orasis, and LENZ with a dual-acting rival.

/themes/custom/pharmaphorum_theme/library/img/article-label-image/ondemand.png

Sales & Marketing

Physicians walking and using tablet devices

How to meet your physicians where they are online

A pharma company’s core mission is to improve patient outcomes. This hinges on effectively influencing HCP clinical behaviour and driving disease education.

indication-specific pricing

Editor's Picks